Journals
Publish with us
Publishing partnerships
About us
Blog
Transboundary and Emerging Diseases
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Transboundary and Emerging Diseases
/
2023
/
Article
/
Tab 2
/
Research Article
An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis
Table 2
Viral shedding in cloacal swabs from chickens in each group.
Group
Challenge virus
Survival rate
Viral shedding (day post challenge)
1
2
3
4
5
6
7
Vaccinated
FAdV-4
10/10
0/10
2/10
0/10
0/10
0/10
0/10
0/10
FAdV-8b
10/10
0/10
3/10
1/10
0/10
0/10
0/10
0/10
FAdV-11
10/10
3/10
4/10
3/10
2/10
0/10
0/10
0/10
Unvaccinated
FAdV-4
0/10
9/10
8/8
2/2
N/A
N/A
N/A
N/A
FAdV-8b
10/10
10/10
10/10
10/10
10/10
10/10
10/10
10/10
FAdV-11
10/10
5/10
10/10
10/10
10/10
10/10
10/10
10/10